Jazz Pharmaceuticals JAZZ Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $293.1M— | —— | $251.41M+135% | -$718.47M-677% | -$92.5M-148% | ||
| $9.1M-3.5% | $9.43M-4.6% | $9.88M-17.2% | $11.93M+14.7% | $10.4M+9.3% | ||
| $74.5M+5.1% | $70.85M-19.6% | $88.13M+36.7% | $64.45M-4.8% | $67.7M-3.5% | ||
| $408.2M+12.6% | $362.52M-23.6% | $474.62M+434% | $88.84M-79.3% | $429.8M+7.8% | ||
| $19.7M+17.8% | $16.73M+10.2% | $15.18M+17.2% | $12.95M-6.8% | $13.9M+4.6% | ||
| $123.1M+133% | -$372.16M-13.5% | -$327.8M+48.9% | -$640.95M-279% | -$169M+12.6% | ||
| -$78.5M— | $0+100% | -$10.83M+91.3% | -$124.49M+84.7% | -$813.5M— | ||
| $452.4M— | —— | —— | -$671.98M-22.0% | -$551M-383% | ||
| $388.5M+12.4% | $345.79M-24.7% | $459.44M+505% | $75.89M-81.8% | $415.9M+7.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Jazz Pharmaceuticals generate?
- Jazz Pharmaceuticals (JAZZ) generated $1.3B in operating cash flow over the trailing twelve months.
- What is Jazz Pharmaceuticals's free cash flow?
- After $64.6M of capital expenditures, Jazz Pharmaceuticals's free cash flow was $1.3B over the trailing twelve months, down 16.1% year over year.
- Where does Jazz Pharmaceuticals's cash flow data come from?
- Every line is extracted from Jazz Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
